David Hickey - 26 Nov 2022 Form 4 Insider Report for BECTON DICKINSON & CO (BDX)

Role
EVP & President, Life Sciences
Signature
Donna Kalazdy, by power of attorney for David Hickey
Issuer symbol
BDX
Transactions as of
26 Nov 2022
Net transactions value
$0
Form type
4
Filing time
29 Nov 2022, 16:24:04 UTC
Previous filing
17 Aug 2022
Next filing
14 Aug 2023
SEC
View on sec.gov

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction BDX Common Stock Award $0 +1,816 +55% $0.000000 5,147 26 Nov 2022 Direct F1

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction BDX Stock Appreciation Rights Award $0 +10,975 $0.000000 10,975 26 Nov 2022 Common Stock 10,975 $238.06 Direct F2
transaction BDX Rights to Common Stock Under Deferred Compensation Plan Award $0 +1,125 +10% $0.000000 12,100 26 Nov 2022 Common Stock 1,125 $238.06 Direct F3
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 Represents restricted stock units awarded under the Becton, Dickinson and Company 2004 Employee and Director Equity-Based Compensation Plan.
F2 The stock appreciation rights vest in four annual installments beginning November 26, 2023.
F3 The securities are distributed following termination of the reporting person's employment or on the date or dates specified by the reporting person